ORBIMED ADVISORS LLC's Net Worth

$3.78 Billion

Estimate Recalculated Mar 1, 2024 08:23PM EST

Who is ORBIMED ADVISORS LLC?

ORBIMED ADVISORS LLC has an estimated net worth of $3.78 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., COMPLETE GENOMICS INC, INSULET CORP, Volcano Corp, AMARIN CORP PLC\UK, Relypsa Inc, ChemoCentryx, Inc., Mirati Therapeutics, Inc., GLAUKOS Corp, INTERCEPT PHARMACEUTICALS INC, Intellia Therapeutics, Inc., ALPINE IMMUNE SCIENCES, INC., SUPERNUS PHARMACEUTICALS INC, PIERIS PHARMACEUTICALS, INC., ViewRay, Inc., CTI BIOPHARMA CORP, Aerpio Pharmaceuticals, Inc., Sierra Oncology, Inc., Adaptimmune Therapeutics PLC, Pacira Pharmaceuticals, Inc., Loxo Oncology, Inc., Sientra, Inc., SELECTA BIOSCIENCES INC, Nabriva Therapeutics AG, Xtant Medical Holdings, Inc., Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Kala Pharmaceuticals, Inc., scPharmaceuticals Inc., SteadyMed Ltd., SYNLOGIC, INC., OTONOMY, INC., Arsanis, Inc., RESPONSE BIOMEDICAL CORP, AVANIR PHARMACEUTICALS, Roka BioScience, Inc., Audentes Therapeutics, Inc., Biodel Inc, AMBIT BIOSCIENCES CORP, Anthera Pharmaceuticals Inc, NxStage Medical, Inc., ACCELERON PHARMA INC, MEMORY PHARMACEUTICALS CORP, ORPHAN MEDICAL INC, Kun Run Biotechnology, Inc., ARYx Therapeutics, Inc., CRYOCOR INC, AEROGEN INC, ATHERSYS, INC / NEW, Corvus Pharmaceuticals, Inc., GIVEN IMAGING LTD, LIFECELL CORP, DOV PHARMACEUTICAL INC, Adicet Bio, Inc., ArriVent Biopharma, Inc., AVEDRO INC, Turning Point Therapeutics, Inc., Keros Therapeutics, Inc., Guardant Health, Inc., CONSTELLATION PHARMACEUTICALS INC, PMV Pharmaceuticals, Inc., Prelude Therapeutics Inc, Crinetics Pharmaceuticals, Inc., Verona Pharma plc, Fusion Pharmaceuticals Inc., SI-BONE, Inc., Inspire Medical Systems, Inc., Repare Therapeutics Inc., Arcutis Biotherapeutics, Inc., Theseus Pharmaceuticals, Inc., Alector, Inc., Janux Therapeutics, Inc., NeuroPace Inc, Edgewise Therapeutics, Inc., Tricida, Inc., Kinnate Biopharma Inc., SpringWorks Therapeutics, Inc., Ikena Oncology, Inc., ARVINAS INC., ARMO BioSciences, Inc., Prevail Therapeutics Inc., Synthorx, Inc., ARS Pharmaceuticals, Inc., Disc Medicine, Inc., GRAYBUG VISION, INC., Acutus Medical, Inc., LogicBio Therapeutics, Inc., 89bio, Inc., Terns Pharmaceuticals, Inc., Oric Pharmaceuticals, Inc., Galecto, Inc., Decibel Therapeutics, Inc., Compass Therapeutics, Inc., Passage BIO, Inc., Principia Biopharma Inc., TELA Bio, Inc., NextCure, Inc., Enliven Therapeutics, Inc., Third Harmonic Bio, Inc., Pandion Therapeutics Holdco LLC, ORTHOVITA INC, and Turnstone Biologics Corp..

SEC CIK

ORBIMED ADVISORS LLC's CIK is 0001055951

Past Insider Trading and Trends

2020 was ORBIMED ADVISORS LLC's most active year for acquiring shares with 92 total transactions. ORBIMED ADVISORS LLC's most active month to acquire stocks was the month of January. 2018 was ORBIMED ADVISORS LLC's most active year for disposing of shares, totalling 124 transactions. ORBIMED ADVISORS LLC's most active month to dispose stocks was the month of February. 2018 saw ORBIMED ADVISORS LLC paying a total of $2,650,974,749.69 for 107,729,051 shares, this is the most they've acquired in one year. In 2018 ORBIMED ADVISORS LLC cashed out on 112,650,096 shares for a total of $365,025,740.64, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc. (ACET) Snapshot price: $3.215

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.01%
3.13M
$2.40
$7,500,000.00
9.77M
Jan 25
Form 4
+12.10%
875K
$2.09
$1,828,750.00
8.11M
Jun 27
Form 4
+765.30%
214.28K
$14.00
$2,999,990.00
242.28K
Dec 10
Form 4
+10.25%
524.35K
$13.00
$6,816,537.00
5.64M
Feb 12
Form 4
6.02M
6.02M
Sep 15 - Sep 17
Form 4
4.83M
$15.00
4.83M
Jan 30
Form 3
0
0
No matching records found

ArriVent Biopharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+143.25%
3.03M
$18.00
$3,999,996.00
5.14M
Jan 30
Form 3
0
0
No matching records found

AVEDRO INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,681.91%
4.09M
4.24M
Feb 19
Form 3
0
0
No matching records found

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.71%
-19.58K
$30.43
-$595,768.40
2.75M
May 22
Form 4
-4.54%
-131.64K
$30.88
-$4,065,439.72
2.77M
May 18 - May 21
Form 4
2.9M
$17.00
2.9M
Oct 10
Form 3
0
0
No matching records found

COMPLETE GENOMICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.75%
-1.21M
$2.75
-$3,304,642.18
10.03M
Jul 11 - Jul 13
Form 4
4.16M
$9.00
4.16M
Nov 16
Form 3
0
0
No matching records found